Walter Isaacson & Business Roundtable CEO Josh Bolten 5/19/25

The House Budget Committee advanced President Trump’s multi trillion-dollar domestic policy package Sunday night, just two days after conservatives voted to reject it. CNBC’s Eamon Javers reports on this and President Trump’s clash with Walmart over tariff-driven price hikes. Walter Isaacson, biographer and Tulane professor, discusses gene editing breakthroughs and biotech innovation amid federal funding cuts, as well as the White House’s relationship with corporate America’s leaders. Then, Business Roundtable CEO Josh Bolten weighs in on how CEOs are responding to Trump-era policies, including the President’s trade agenda. Plus, Regeneron Pharmaceuticals has announced plans to acquire most of 23andMe’s assets for $256 million. Walter Issacson       18:22Josh Bolten          28:39 In this episode:Eamon Javers, @EamonJaversWalter Isaacson, @WalterIsaacsonBecky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinZach Vallese, @zachvallese Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.